Dan, I like BR under $30 and UCL under $27 for first thirds.
My allocations are currently: 90/10-30%, Income-60%, Cap App 10%. I have cranked up the income by 10% over the 90/10 due to the huge premiums being offered on options.
I've been listing a lot of picks the last month of so. On the cap app side, I like ASA, Stillwater around $25, my usual suspects in biotech (GZTC, GZTR, LGND) and medical miscellany (VASO, DRMD). I also like a value story, Velcro (Velcf). Once its got you, you stick. <g> I like a vulture play, Federal Mogul. (FMO). Still love Ancor, Vignette and Allaire in the tech area.
I list few of my income plays due to the fact that most of them are in a partnership where confidentiality is more important than performance. Most of these are still neutral to slightly bearish. However, a few slightly bullish credit spreads/Buy Writes/Spread Conversions I have put on lately in my own IRA and not in the partnership include Ancor, Vignette, VerticalNet, Bea Systems, Exodus, Tibia, Vitria, and Allaire.
On the 90/10, I currently have very low representation, with it more like 96/4. Most of the Internut, biotech index and small co. stocks on which I bought puts hit the wall in May and I haven't replaced them. I still have puts on a few large techs, MU, Gate, Intel and a third left on Oracle. I also have a few specials such as Sanmina and CMGI, but I am hoping for summer and Xmas rallies to make the prices really stupid again.
I also own some country and specialized CEFs: FPF, AFF, SGF, JEQ, and Jakarta Growth.
I hate royalty trusts because what they call income is mostly your own capital being returned to you, hence the "tax break." I would rather wait in cash for a good co. or buy a third of PEO for protection. |
